Reporting a lethal drug interaction occurred during evaluation of insulin resistance in mice polycystic ovary model
DOI:
https://doi.org/10.3329/bjp.v13i2.36001Keywords:
Drug interaction, Insulin resistance, Mice, Polycystic ovary modelDownloads
20
17
References
Ahmadi M, Rostamzadeh A, Fathi F, Mohammadi M, Rezaie MJ. The effect of melatonin on histological changes of ovary in induced polycystic ovary syndrome model in mice. Middle East Fertil Soc J. 2017; 22: 255-59.
Ahmadi SAY, Tavafi M, Ahmadi PS. A critical approach to administration of low-dose aspirin (LDA) to improve implantation success. Int J Women's Health Reprod Sci. 2015; 3: 223-24.
Borna S, Akbari S, Eftekhar T, Mostaan F. Cushing's syndrome during pregnancy secondary to adrenal adenoma. Acta Medica Iranica. 2012; 50: 76.
Boroujeni MB, Boroujeni NB, Gholami M. The effect of progesterone treatment after ovarian induction on endometrial VEGF gene expression and its receptors in mice at pre-implantation time. Iranian J Basic Med Sci. 2016; 19: 252.
Kalhori Z, Azadbakht M, Bazdar A, Zeinali H. Polycystic ovary induction in mouse by testosterone enanthate. J Fasa Univ Med Sci. 2014; 3: 387-91.
Kapoor D, Goodwin E, Channer K, Jones T. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006; 154: 899-906.
Keshavarz M, Moradi S, Emami Z, Rohani F. Association between serum 25(OH) vitamin D and metabolic disturbances in polycystic ovary syndrome. Neth J Med. 2017; 5: 191-96.
Yari F, Aeinfar K, Abbaszadeh S, Anbari K, Ahmadi SAY. Polycystic ovary syndrome is affected and protected by DD and DI genotypes of angiotensin converting enzyme, respectively: An update of a meta-analysis. Int J Women's Health Reprod Sci. 2017; 5: 164-70.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).